{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Algie post-zona : Questions médicales les plus fréquentes",
"headline": "Algie post-zona : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Algie post-zona : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-13",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Algie post-zona"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Névralgie",
"url": "https://questionsmedicales.fr/mesh/D009437",
"about": {
"@type": "MedicalCondition",
"name": "Névralgie",
"code": {
"@type": "MedicalCode",
"code": "D009437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.612.664"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Algie post-zona",
"alternateName": "Neuralgia, Postherpetic",
"code": {
"@type": "MedicalCode",
"code": "D051474",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Song Cao",
"url": "https://questionsmedicales.fr/author/Song%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Dexin Zhang",
"url": "https://questionsmedicales.fr/author/Dexin%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Jie Yuan",
"url": "https://questionsmedicales.fr/author/Jie%20Yuan",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Ying Li",
"url": "https://questionsmedicales.fr/author/Ying%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China."
}
},
{
"@type": "Person",
"name": "Yuanyuan Ding",
"url": "https://questionsmedicales.fr/author/Yuanyuan%20Ding",
"affiliation": {
"@type": "Organization",
"name": "Department of Pain Management, Shengjing Hospital of China Medical University, Shenyang, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37098622",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12969-023-00819-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association Between Fat Graft Retention and Blood Flow in Localized Scleroderma Patients: A Pilot Study.",
"datePublished": "2022-06-23",
"url": "https://questionsmedicales.fr/article/35814764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fmed.2022.945691"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evans' syndrome following vaccination with ChAdOx1 nCoV-19 in a patient with new-onset localized scleroderma.",
"datePublished": "2022-11-21",
"url": "https://questionsmedicales.fr/article/36483231",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/dr.2022.9470"
}
},
{
"@type": "ScholarlyArticle",
"name": "Juvenile Scleroderma.",
"datePublished": "2023-11-15",
"url": "https://questionsmedicales.fr/article/37966656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12098-023-04894-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma.",
"datePublished": "2024-01-01",
"url": "https://questionsmedicales.fr/article/38364378",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5826/dpc.1401a23"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Névralgie",
"item": "https://questionsmedicales.fr/mesh/D009437"
},
{
"@type": "ListItem",
"position": 6,
"name": "Algie post-zona",
"item": "https://questionsmedicales.fr/mesh/D051474"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Algie post-zona - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Algie post-zona",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Algie post-zona",
"description": "Comment diagnostique-t-on l'algie post-zona ?\nQuels examens peuvent être réalisés ?\nQuels symptômes indiquent une algie post-zona ?\nPeut-on confondre l'algie post-zona avec d'autres douleurs ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Algie post-zona",
"description": "Quels sont les symptômes principaux de l'algie post-zona ?\nLa douleur est-elle constante ou intermittente ?\nY a-t-il des symptômes associés ?\nComment la douleur est-elle décrite par les patients ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Algie post-zona",
"description": "Peut-on prévenir l'algie post-zona ?\nQui devrait se faire vacciner contre le zona ?\nY a-t-il des mesures à prendre après une éruption de zona ?\nLa gestion du stress aide-t-elle à prévenir l'algie ?\nLes soins de la peau sont-ils importants après le zona ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Algie post-zona",
"description": "Quels traitements sont efficaces contre l'algie post-zona ?\nLes médicaments topiques sont-ils utiles ?\nLa physiothérapie peut-elle aider ?\nY a-t-il des traitements non médicamenteux ?\nLes traitements sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Algie post-zona",
"description": "Quelles sont les complications possibles de l'algie post-zona ?\nL'algie post-zona peut-elle affecter la qualité de vie ?\nY a-t-il un risque de dépression avec l'algie post-zona ?\nLes douleurs peuvent-elles s'aggraver avec le temps ?\nDes infections peuvent-elles survenir après le zona ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Algie post-zona",
"description": "Quels sont les facteurs de risque de l'algie post-zona ?\nLe stress est-il un facteur de risque ?\nLes personnes atteintes de maladies chroniques sont-elles à risque ?\nLes femmes sont-elles plus à risque que les hommes ?\nL'immunosuppression augmente-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D051474?mesh_terms=Scleroderma,+Localized&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'algie post-zona ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et l'examen physique, sans tests spécifiques."
}
},
{
"@type": "Question",
"name": "Quels examens peuvent être réalisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme l'IRM peuvent être utilisés pour exclure d'autres causes de douleur."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une algie post-zona ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une douleur intense, brûlante ou lancinante dans la zone de l'éruption cutanée est typique."
}
},
{
"@type": "Question",
"name": "Peut-on confondre l'algie post-zona avec d'autres douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec d'autres douleurs neuropathiques ou musculo-squelettiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique d'une infection par le virus varicelle-zona est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de l'algie post-zona ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur intense, hypersensibilité et parfois démangeaisons."
}
},
{
"@type": "Question",
"name": "La douleur est-elle constante ou intermittente ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur peut être constante ou survenir par épisodes, souvent aggravée par le toucher."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la fatigue, l'anxiété et des troubles du sommeil peuvent être présents."
}
},
{
"@type": "Question",
"name": "Comment la douleur est-elle décrite par les patients ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients décrivent souvent la douleur comme brûlante, lancinante ou en coup de poignard."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la durée des symptômes peuvent varier considérablement entre les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir l'algie post-zona ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination contre le zona peut réduire le risque de développer l'algie post-zona."
}
},
{
"@type": "Question",
"name": "Qui devrait se faire vacciner contre le zona ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les adultes de 50 ans et plus sont recommandés pour recevoir le vaccin contre le zona."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures à prendre après une éruption de zona ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter un médecin rapidement après une éruption pour un traitement précoce."
}
},
{
"@type": "Question",
"name": "La gestion du stress aide-t-elle à prévenir l'algie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion du stress peut aider à réduire le risque de douleurs chroniques après le zona."
}
},
{
"@type": "Question",
"name": "Les soins de la peau sont-ils importants après le zona ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir la peau propre et hydratée peut aider à prévenir les complications cutanées."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre l'algie post-zona ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des analgésiques, des anticonvulsivants et des antidépresseurs."
}
},
{
"@type": "Question",
"name": "Les médicaments topiques sont-ils utiles ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des crèmes anesthésiques peuvent soulager la douleur localement dans certains cas."
}
},
{
"@type": "Question",
"name": "La physiothérapie peut-elle aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La physiothérapie peut aider à gérer la douleur et améliorer la fonction dans certains cas."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements non médicamenteux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la thérapie cognitivo-comportementale peuvent être bénéfiques."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie, et certains patients peuvent ne pas répondre aux thérapies."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'algie post-zona ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des douleurs chroniques, des troubles du sommeil et de l'anxiété."
}
},
{
"@type": "Question",
"name": "L'algie post-zona peut-elle affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique peut significativement impacter la qualité de vie et le bien-être."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de dépression avec l'algie post-zona ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique peut augmenter le risque de dépression chez les patients."
}
},
{
"@type": "Question",
"name": "Les douleurs peuvent-elles s'aggraver avec le temps ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, la douleur peut devenir plus intense et persistante avec le temps."
}
},
{
"@type": "Question",
"name": "Des infections peuvent-elles survenir après le zona ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections cutanées peuvent survenir si la peau est lésée pendant l'éruption."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'algie post-zona ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, un système immunitaire affaibli et des antécédents de zona."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'algie post-zona."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes de maladies chroniques sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent augmenter le risque de développer l'algie post-zona."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque que les hommes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les femmes peuvent être légèrement plus à risque que les hommes."
}
},
{
"@type": "Question",
"name": "L'immunosuppression augmente-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunosupprimées ont un risque accru de développer l'algie post-zona."
}
}
]
}
]
}
Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permane...
In this cross-sectional study, caregivers of juvenile LS or SSc patients were recruited from a virtual family scleroderma educational conference and a juvenile scleroderma online interest group. The s...
The response rate was 61% (73/120), with 38 parents of LS patients and 31 parents of SSc patients. Most patients were female (80%) and over half were non-Hispanic white (55%). Most families had at lea...
Caregivers of children with LS or SSc reported numerous common barriers to the diagnosis, treatment, and ongoing care of juvenile scleroderma. The major problem highlighted was the lack of knowledge o...
Microcirculation plays a vital role in scleroderma physiopathology and the mechanism of fat survival....
This study aims to assess the blood perfusion change after fat grafting and evaluate the relationship between blood perfusion and fat graft retention in patients with localized scleroderma (LS)....
A pilot study was conducted in patients with LS receiving autologous fat grafting (AFG). Fat graft retention measured by magnetic resonance imaging (MRI) analysis and blood flow perfusion measured by ...
The fat retention at the 6-month follow-up was 34.56 ± 11.89 percent. At the 6th month of follow-up, the relative blood perfusion at the lesion area was 115.08 ± 14.39 PU, significantly higher than 10...
Local blood perfusion in the lesion area relatively increased after AFG, but no direct relationship was found between fat retention and increased blood supply....
Growing evidence suggests that COVID-19 vaccines can induce hematological conditions. Here, we report a case of Evans' syndrome, a combination of immune thrombocytopenic purpura and autoimmune hemolyt...
Localised scleroderma and systemic sclerosis are rare chronic fibrosing disorders seen in children, and are collectively referred to as Juvenile Scleroderma. Histopathology of the two forms is non-dis...
Morphea localized scleroderma (LS) is a rare skin disease with unknown pathogenesis, which causes sclerosis of the dermis and subcutaneous tissue....
It was aimed to compare the characteristics of patients with pediatric and adult-onset morphea....
A retrospective analysis was performed on the records of 183 adult morphea patients. The demographics, clinical and laboratory characteristics, and treatment options of the patients were recorded. Adu...
Twenty-two percent (N = 41) of the patients had pediatric-onset morphea (POLS) and 77.6% (n=142) had adult-onset morphea (AOLS). While POLS had a higher head-neck involvement, AOLS had a higher breast...
Clinical characteristics and accompanying laboratory anomalies of the patients with morphea depend on the age of onset, involvement areas and the types of morphea, having such data readily available s...
This case report details a rare presentation of diffuse scleroderma, where a 38-year-old female developed hypertensive encephalopathy due to scleroderma renal crisis (SRC). SRC, characterized by sudde...
Scleroderma yunnanense, an ectomycorrhizal fungus, is a popular edible mushroom within the Yunnan Province of Southwest China that holds great ecological and economic implications. However, despite it...
Scleroderma is a complex chronic progressive immune-mediated disease that causes fibrosis of the skin and internal organs, and vasculopathy.Ear involvement has been poorly studied in patients with scl...
The national temporal bone database was reviewed for cases with scleroderma. Clinical case review and correlative otopathologic analysis. Middle and inner ear otopathologic analysis was performed foll...
Two patients (three cases) with a history of serologically confirmed scleroderma were identified. Both individuals reported tinnitus and demonstrated bilateral moderate to severe down-sloping sensorin...
Fibrosis, inflammation, and vascular changes were observed in the middle and inner ear in patients with scleroderma. Findings have implications for understanding hearing and vestibular dysfunction in ...
Retrospective study....
The optimal timing of reconstruction for patients with facial localized scleroderma is uncertain. The purpose of this study was to compare the outcomes of autologous fat transplantation in adolescent ...
Adolescent (age 10-19 years) and adult (age >19 years) patients with no previous surgery were enrolled (n = 10, each group). Preoperative magnetic resonance imaging (MRI), blood tests and dermatologic...
There was no significant difference in sex, body mass index, disease severity, or volume of injected fat between the two groups (p > 0.05), except for age (p < 0.05). The one-year postoperative fat gr...
In stable localized scleroderma, the initial autologous fat transplantation was equally effective for facial contour deformity improvement, with no significant difference in fat graft retention or sat...
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes ...